Michael Thomas Henderson, Director: Spyre Therapeutics SYRE Sell · Filed 06/23

Trade details

Type: Insider sale
Amount: $2,000,000
Shares · price: 20,000 sh · $100.00 a share
Held after: 68,606 sh
Stock: Spyre Therapeutics SYRE
Person: Michael Thomas HendersonDirector
Trade date: 26/06/22
Filed: 26/06/23
Days to filing: 1 days

Sold 22.6% of holdings

Share of holding sold: 22.6%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Michael Thomas Henderson's recent trades

Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
Michael Thomas HendersonDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$198.9K
2,305 sh
$198.9K
Filed 06/12
Traded 06/10

Michael Thomas Henderson, Director — sold $2M of Spyre Therapeutics SYRE · 22.6% of holdings · 10b5-1 plan | Whalegun